ABOUT US
We are committed to optimize the patient experience for patients with chronic inflammatory skin conditions by introducing novel topical therapies designed to combine fast relief of symptoms with high convenience in daily routines. Higher satisfaction and less discontinuation address the needs of patients, physicians and societies. Read more about MC2 Therapeutics.
Platform
Our PAD™ Technology enables a new class of creams and eye drops (PAD™ Vehicles) that offer a number of unique advantages in the development of new topical therapies. Read more about our platform.
Pipeline
Our current pipeline includes programs in major chronic inflammatory diseases such as psoriasis, atopic dermatitis, pruritus and dry and sensitive skin and eyes. Read more about our pipeline.
